首页> 外文期刊>Lung cancer: Journal of the International Association for the Study of Lung Cancer >Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)
【24h】

Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018)

机译:基础科学恶性间皮瘤研究进展 - 关于第14届国际间皮瘤利益集团会议综述(IMIG2018)

获取原文
获取原文并翻译 | 示例
           

摘要

Here we summarize the most recent update of mesothelioma research in basic science presented at the 14th iMig2018 international conference. The symposium of basic science track mainly focused on the drivers of mesothelioma initiation and progression, molecular pathogenesis, and perspectives on potential therapeutic approaches. This review covers several promising fields including strategies efficiently inhibiting YAP/TAZ functions or their critical downstream targets, heparanase inhibitors, RAN depletion, and MIF/CD74 inhibitors that may be developed as novel therapeutic approaches. In addition, targeting mesothelioma stem cells by depleting M2-polarized macrophages in tumor microenvironment or blocking Tnfsf18 (GITRL)-GITR signalling might be translated into therapeutic modalities in mesothelioma treatment.
机译:在这里,我们总结了第14届IMIG2018国际会议上提出的基础科学中最近更新的基础科学研究。 基础科学轨道研讨会主要专注于间皮瘤起始和进展,分子发病机制的驱动力,分子发病机制和潜在治疗方法的观点。 本综述涵盖了几个有希望的领域,包括有效地抑制YAP / TAZ功能的策略或其临界下游靶标,肝素酶抑制剂,RAN耗尽和MIF / CD74抑制剂,可以开发为新的治疗方法。 另外,通过在肿瘤微环境中耗尽M2偏振巨噬细胞或阻断TNFSF18(GITR1) - 可转化为间皮瘤治疗中的治疗方式来靶向间皮瘤干细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号